Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Gross Profit (2018 - 2025)

Dna X (SONM) has disclosed Gross Profit for 8 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Profit fell 57.09% year-over-year to $1.8 million, compared with a TTM value of $10.8 million through Sep 2025, down 28.83%, and an annual FY2024 reading of $9.9 million, down 48.66% over the prior year.
  • Gross Profit was $1.8 million for Q3 2025 at Dna X, up from $845000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $8.4 million in Q1 2025 and bottomed at -$487000.0 in Q4 2021.
  • Average Gross Profit over 5 years is $3.1 million, with a median of $2.9 million recorded in 2024.
  • The sharpest move saw Gross Profit crashed 113.06% in 2021, then skyrocketed 907.39% in 2022.
  • Year by year, Gross Profit stood at -$487000.0 in 2021, then surged by 907.39% to $3.9 million in 2022, then surged by 30.21% to $5.1 million in 2023, then plummeted by 103.57% to -$183000.0 in 2024, then surged by 1092.35% to $1.8 million in 2025.
  • Business Quant data shows Gross Profit for SONM at $1.8 million in Q3 2025, $845000.0 in Q2 2025, and $8.4 million in Q1 2025.